Cited by 925Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsNuclear Receptors and Signaling

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats

Open access

Holmqvist, Staffan, Chutna, Oldriska, Bousset, Luc, Aldrin-Kirk, Patrick, Li, Wen, Björklund, Tomas, Wang, Zhan-You, Roybon, Laurent, Melki, Ronald, Li, Jia-Yi·2014·Acta Neuropathologica

DOI 10.1007/s00401-014-1343-6

Open this paper in CoChat — free account

Abstract

The cellular hallmarks of Parkinson's disease (PD) are the loss of nigral dopaminergic neurons and the formation of α-synuclein-enriched Lewy bodies and Lewy neurites in the remaining neurons. Based on the topographic distribution of Lewy bodies established after autopsy of brains from PD patients, Braak and coworkers hypothesized that Lewy pathology primes in the enteric nervous system and spreads to the brain, suggesting an active retrograde transport of α-synuclein (the key protein component in Lewy bodies), via the vagal nerve. This hypothesis, however, has not been tested experimentally thus far. Here, we use a human PD brain lysate containing different forms of α-synuclein (monomeric, oligomeric and fibrillar), and recombinant α-synuclein in an in vivo animal model to test this hypothesis. We demonstrate that α-synuclein present in the human PD brain lysate and distinct recombinant α-synuclein forms are transported via the vagal nerve and reach the dorsal motor nucleus of the vagus in the brainstem in a time-dependent manner after injection into the intestinal wall. Using live cell imaging in a differentiated neuroblastoma cell line, we determine that both slow and fast components of axonal transport are involved in the transport of aggregated α-synuclein. In conclusion, we here provide the first experimental evidence that different α-synuclein forms can propagate from the gut to the brain, and that microtubule-associated transport is involved in the translocation of aggregated α-synuclein in neurons.

Integrity signals

Registry

Crossref · 10.1007/s00401-014-1343-6

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Mobility measurement by analysis of fluorescence photobleaching recovery kinetics
Axelrod, D., Koppel, D. E., Schlessinger, J., Elson, E. L., & Webb, W. W. (1976) · Biophysical Journal · doi:10.1016/s0006-3495(76)85755-4 · Cited by 2,717
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Self-citation
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722
Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
In vivo demonstration that α-synuclein oligomers are toxic
Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100976108 · Cited by 1,463

Flagged first, then by citations

Show all 51 references

Sorted by citations

Items 101–200 of 925

Curli-Containing Enteric Biofilms Inside and Out: Matrix Composition, Immune Recognition, and Disease Implications
Tursi, S. A., & Tükel, Ç. (2018) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00028-18 · Cited by 171
Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics
Peterson, C. T. (2020) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x20957225 · Cited by 160
Extracellular Interactions of Alpha-Synuclein in Multiple System Atrophy
Valdinocci, D., Radford, R. A. W., Goulding, M., Hayashi, J., Chung, R. S., & Pountney, D. L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124129 · Cited by 161
Dietary polyphenols: Regulate the advanced glycation end products-RAGE axis and the microbiota-gut-brain axis to prevent neurodegenerative diseases
Li, Y., Peng, Y., Shen, Y., Zhang, Y., Liu, L., & Yang, X. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2076064 · Cited by 156
Invited review: Prion‐like transmission and spreading of tau pathology
Clavaguera, F., Hench, J., Goedert, M., & Tolnay, M. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12197 · Cited by 156
Implications of the Gut Microbiome in Parkinson's Disease
Elfil, M., Kamel, S., Kandil, M. A., Koo, B. B., & Schaefer, S. M. (2020) · Movement Disorders · doi:10.1002/mds.28004 · Cited by 160
Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links
Lee, H.-S., Lobbestael, E., Vermeire, S., Sabino, J., & Cleynen, I. (2021) · Gut · doi:10.1136/gutjnl-2020-322429 · Cited by 151
Probiotics for Parkinson’s Disease
Gazerani, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174121 · Cited by 156
T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease
Campos‐Acuña, J., Elgueta, D., & Pacheco, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00239 · Cited by 150
Enteric nervous system manifestations of neurodegenerative disease
Chalazonitis, A., & Rao, M. (2018) · Brain Research · doi:10.1016/j.brainres.2018.01.011 · Cited by 152
Association of Intestinal Disorders with Parkinson’s Disease and Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Fu, P., Gao, M., & Yung, K. K. L. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00607 · Cited by 146
Diet in Parkinson’s Disease: Critical Role for the Microbiome
Jackson, A., Forsyth, C. B., Shaikh, M., Voigt, R. M., Engen, P. A., Ramirez, V., & Keshavarzian, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01245 · Cited by 145
Structural and functional properties of prefibrillar α-synuclein oligomers
Pieri, L., Madiona, K., & Melki, R. (2016) · Scientific Reports · doi:10.1038/srep24526 · Cited by 149
Self-citation
Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease
Fitzgerald, E., Murphy, S. A., & Martinson, H. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00369 · Cited by 151
Linking the Endoplasmic Reticulum to Parkinson’s Disease and Alpha-Synucleinopathy
Colla, E. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00560 · Cited by 138
Mechanisms of protein toxicity in neurodegenerative diseases
Chung, C. G., Lee, H., & Lee, S. B. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2854-4 · Cited by 142
NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy
Earls, R. H., Menees, K. B., Chung, J., Gutekunst, C., Lee, H. J., Hazim, M. G., Rada, B., Wood, L. B., & Lee, J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909110117 · Cited by 146
The Gut and Parkinson's Disease—A Bidirectional Pathway
Santos, S. F., de Oliveira, H. L., Yamada, E. S., Neves, B. C., & Pereira, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00574 · Cited by 148
Inflammatory bowel diseases and Parkinson's disease
Brudek, T. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191729 · Cited by 139
Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice
Earls, R. H., Menees, K. B., Chung, J., Barber, J., Gutekunst, C.-A., Hazim, M. G., & Lee, J.-K. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1636-8 · Cited by 138
“It has been suggested that α-syn pathology may begin within the ENS and propagate up to midbrain regions through the vagal nerve afferents [35, 54, 55].”
Background
Gut inflammation triggers C/EBPβ/δ‐secretase‐dependent gut‐to‐brain propagation of Aβ and Tau fibrils in Alzheimer’s disease
Chen, C., Zhou, Y., Wang, H., Alam, A. M., Kang, S. S., Ahn, E. H., Liu, X., Jia, J., & Ye, K. (2021) · The EMBO Journal · doi:10.15252/embj.2020106320 · Cited by 138
The enigma and implications of brain hemispheric asymmetry in neurodegenerative diseases
Lubben, N., Ensink, E., Coetzee, G. A., & Labrie, V. (2021) · Brain Communications · doi:10.1093/braincomms/fcab211 · Cited by 139
Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
Brás, I. C., & Outeiro, T. F. (2021) · Cells · doi:10.3390/cells10020375 · Cited by 136
Probiotics synergized with conventional regimen in managing Parkinson’s disease
Sun, H., Zhao, F., Liu, Y., Ma, T., Jin, H., Quan, K., Leng, B., Zhao, J., Yuan, X., Li, Z., et al. (2022) · npj Parkinson's Disease · doi:10.1038/s41531-022-00327-6 · Cited by 136
How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology
Borghammer, P. (2017) · Movement Disorders · doi:10.1002/mds.27138 · Cited by 143
Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
Ganguly, U., Singh, S., Pal, S., Prasad, S., Agrawal, B. K., Saini, R. V., & Chakrabarti, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.702639 · Cited by 139
Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's DiseasesPreprint
Braak, H., & Tredici, K. D. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023630 · Cited by 132
The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease
Baizabal-Carvallo, J. F., & Alonso-Juarez, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.030 · Cited by 130
Gastrointestinal dysfunction in Parkinson’s disease: Molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation
Metta, V., Leta, V., Mrudula, K. R., Prashanth, L. K., Goyal, V., Borgohain, R., Chung-Faye, G., & Chaudhuri, K. R. (2022) · Journal of Neurology · doi:10.1007/s00415-021-10567-w · Cited by 130
Gastrointestinal Dysfunctions in Parkinson’s Disease: Symptoms and Treatments
Poirier, A.-A., Aubé, B., Côté, M., Morin, N., Di Paolo, T., & Soulet, D. (2016) · Parkinson s Disease · doi:10.1155/2016/6762528 · Cited by 130
The immunological functions of the Appendix: An example of redundancy?
Girard-Madoux, M. J. H., de Agüero, M. G., Ganal-Vonarburg, S. C., Mooser, C., Belz, G. T., Macpherson, A. J., & Vivier, É. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.02.005 · Cited by 131
Mining microbes for mental health: determining the role of microbial metabolic pathways in human brain health and disease
Spichak, S., Bastiaanssen, T. F. S., Berding, K., Vlckova, K., Clarke, G., Dinan, T. G., & Cryan, J. F. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.044 · Cited by 127
Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease
Farrand, A. Q., Helke, K. L., Gregory, R. A., Gooz, M. B., Hinson, V. K., & Boger, H. A. (2017) · Brain stimulation · doi:10.1016/j.brs.2017.08.008 · Cited by 130
ɑ-Synuclein strains and seeding in Parkinson’s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences
Peelaerts, W., Bousset, L., Baekelandt, V., & Melki, R. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2839-5 · Cited by 128
Self-citation
Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases
Miller, A. L., Bessho, S., Grando, K. C. M., & Tükel, Ç. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.638867 · Cited by 136
Prion-Like Mechanisms in Parkinson’s Disease
Ma, J., Gao, J., Wang, J., & Xie, A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00552 · Cited by 134
Three-dimensional modeling of human neurodegeneration: brain organoids coming of age
Grenier, K., Kao, J., & Diamandis, P. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0500-7 · Cited by 131
The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses
Jan, A., Gonçalves, N. P., Vægter, C. B., Jensen, P. H., & Ferreira, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158338 · Cited by 133
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Tofaris, G. K. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04240-2 · Cited by 126
Alpha‐synuclein propagation: New insights from animal models
Dehay, B., Vila, M., Bézard, E., Brundin, P., & Kordower, J. H. (2015) · Movement Disorders · doi:10.1002/mds.26370 · Cited by 126
Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats
Berge, N. V. D., Ferreira, N., Mikkelsen, T. W., Alstrup, A. K. O., Tamgüney, G., Karlsson, P., Terkelsen, A. J., Nyengaard, J. R., Jensen, P. H., & Borghammer, P. (2021) · Brain · doi:10.1093/brain/awab061 · Cited by 126
The Gut-Brain Axis: Two Ways Signaling in Parkinson’s Disease
Dogra, N., Mani, R. J., & Katare, D. P. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01066-7 · Cited by 121
Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson’s disease
Nishiwaki, H., Ito, M., Hamaguchi, T., Maeda, T., Kashihara, K., Tsuboi, Y., Ueyama, J., Yoshida, T., Hanada, H., Takeuchi, I., et al. (2022) · npj Parkinson's Disease · doi:10.1038/s41531-022-00328-5 · Cited by 116
New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
Zhang, G., Xia, Y. F., Wan, F. J., Ma, K., Guo, X., Kou, L., Yin, S., Han, C., Liu, L., Huang, J., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00370 · Cited by 116
Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved
Vasili, E., Dominguez‐Meijide, A., & Outeiro, T. F. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00107 · Cited by 121
Lipopolysaccharide animal models of Parkinson’s disease: Recent progress and relevance to clinical disease
Deng, I. B., Corrigan, F., Zhai, G., Zhou, X., & Bobrovskaya, L. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100060 · Cited by 129
Intra‐gastrointestinal amyloid‐β1–42 oligomers perturb enteric function and induce Alzheimer's disease pathology
Sun, Y., Sommerville, N. R., Liu, J. Y. H., Ngan, M. P., Poon, D., Ponomarev, E. D., Lu, Z., Kung, J. S. C., & Rudd, J. A. (2020) · The Journal of Physiology · doi:10.1113/jp279919 · Cited by 118
Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice
Kishimoto, Y., Zhu, W. S., Hosoda, W., Sen, J. M., & Mattson, M. P. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08539-5 · Cited by 115
A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer’s Disease
Sun, M., Ma, K., Wen, J., Wang, G., Zhang, C., Li, Q., Bao, X., & Wang, H. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190872 · Cited by 113
Gut-brain and brain-gut axis in Parkinson’s disease models: effects of a uridine and fish oil diet
Perez-Pardo, P., Dodiya, H. B., Broersen, L. M., Douna, H., van Wijk, N., Lopes da Silva, S., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1294555 · Cited by 111
Altered Gut Microbiota in Parkinson’s Disease Patients/Healthy Spouses and Its Association with Clinical Features
Zhang, F., Yue, L., Fang, X., Wang, G., Li, C., Sun, X., Jia, X., Yang, J., Song, J., Zhang, Y., et al. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.10.034 · Cited by 111
Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson’s Disease Models
Garrido‐Gil, P., Rodriguez-Perez, A. I., Dominguez‐Meijide, A., Guerra, M. J., & Labandeira-García, J. L. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0937-8 · Cited by 114
Structural and Functional Insights into α-Synuclein Fibril Polymorphism
Mehra, S., Gadhe, L. G., Bera, R., Sawner, A. S., & Maji, S. K. (2021) · Biomolecules · doi:10.3390/biom11101419 · Cited by 111
Gut microbiota-derived metabolites and their importance in neurological disorders
Swer, N. M., Venkidesh, B. S., Murali, T. S., & Mumbrekar, K. D. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08038-0 · Cited by 120
Hydrogen Sulfide Produced by Gut Bacteria May Induce Parkinson’s Disease
Murros, K. E. (2022) · Cells · doi:10.3390/cells11060978 · Cited by 105
Alpha Synuclein: Neurodegeneration and Inflammation
Forloni, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065914 · Cited by 116
The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson’s disease
Vargas, J., Grudina, C., & Zurzolo, C. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.01.012 · Cited by 112
Parkinson’s progression prediction using machine learning and serum cytokines
Rastegar, D. A., Ho, N., Halliday, G. M., & Dzamko, N. L. (2019) · npj Parkinson s Disease · doi:10.1038/s41531-019-0086-4 · Cited by 109
Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease
Chiang, H., & Lin, C. (2019) · Journal of Movement Disorders · doi:10.14802/jmd.18067 · Cited by 107
Synucleinopathies: Where we are and where we need to go
Brás, I. C., Dominguez‐Meijide, A., Gerhardt, E., Koss, D. J., Lázaro, D. F., Santos, P. I., Vasili, E., Xylaki, M., & Outeiro, T. F. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14965 · Cited by 106
Determinants of seeding and spreading of α-synuclein pathology in the brain
Henrich, M. T., Geibl, F. F., Harini, L., Stegmann, A., Giasson, B. I., Mao, X., Dawson, V. L., Dawson, T. M., Oertel, W. H., & Surmeier, D. J. (2020) · Science Advances · doi:10.1126/sciadv.abc2487 · Cited by 104
Neurodegenerative disorders and gut-brain interactions
Singh, A., Dawson, T. M., & Kulkarni, S. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143775 · Cited by 104
Gut microbiota differences between healthy older adults and individuals with Parkinson’s disease: A systematic review
Nuzum, N. D., Loughman, A., Szymlek-Gay, E. A., Hendy, A., Teo, W.-P., & Macpherson, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.02.003 · Cited by 103
TLR2 and TLR4 in Parkinson’s disease pathogenesis: The environment takes a toll on the gut
Gorecki, A. M., Anyaegbu, C. C., & Anderton, R. S. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00271-0 · Cited by 103
Neuroinvasion of α-Synuclein Prionoids after Intraperitoneal and Intraglossal Inoculation
Breid, S., Bernis, M. E., Babila, J. T., Garza, M. C., Wille, H., & Tamgüney, G. (2016) · Journal of Virology · doi:10.1128/jvi.01399-16 · Cited by 103
Initiation of Parkinson’s disease from gut to brain by δ-secretase
Ahn, E. H., Kang, S. S., Liu, X., Chen, G., Zhang, Z., Chandrasekharan, B. P., Alam, A. M., Neish, A. S., Cao, X., & Ye, K. (2019) · Cell Research · doi:10.1038/s41422-019-0241-9 · Cited by 103
The gut microbiome in Parkinson's disease: A culprit or a bystander?
Keshavarzian, A., Engen, P. A., Bonvegna, S., & Cilia, R. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.01.004 · Cited by 108
Gut bacterial composition in a mouse model of Parkinson’s disease
Perez-Pardo, P., Dodiya, H. B., Engen, P. A., Naqib, A., Forsyth, C. B., Green, S. J., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0202 · Cited by 102
Does vagotomy reduce the risk of Parkinson's disease?
Tysnes, O., Kenborg, L., Herlofson, K., Steding‐Jessen, M., Horn, A., Olsen, J. H., & Reichmann, H. (2015) · Annals of Neurology · doi:10.1002/ana.24531 · Cited by 102
Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
Zheng, S.-Y., Li, H.-X., Xu, R.-C., Miao, W.-T., Dai, M.-Y., Ding, S.-T., & Liu, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101347 · Cited by 101
Fermented Soy Products: Beneficial Potential in Neurodegenerative Diseases
Jang, C. H., Oh, J., Lim, J. S., Kim, H. J., & Kim, J.-S. (2021) · Foods · doi:10.3390/foods10030636 · Cited by 100
The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration
Hinkle, J. T., Dawson, V. L., & Dawson, T. M. (2019) · Movement Disorders · doi:10.1002/mds.27718 · Cited by 100
Extracellular Vesicles as Nanotherapeutics for Parkinson’s Disease
Leggio, L., Paternò, G., Vivarelli, S., L’Episcopo, F., Tirolo, C., Raciti, G., Pappalardo, F., Giachino, C., Caniglia, S., Serapide, M. F., et al. (2020) · Biomolecules · doi:10.3390/biom10091327 · Cited by 100
Role of Gut Microbiota in Neurological Disorders and Its Therapeutic Significance
Tiwari, P., Dwivedi, R., Bansal, M., Tripathi, M., & Dada, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041650 · Cited by 108
The Intestinal Barrier in Parkinson’s Disease: Current State of Knowledge
van IJzendoorn, S. C. D., & Derkinderen, P. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191707 · Cited by 97
Quadruple abnormal protein aggregates in brainstem pathology and exogenous metal-rich magnetic nanoparticles (and engineered Ti-rich nanorods). The substantia nigrae is a very early target in young urbanites and the gastrointestinal tract a key brainstem portal
Calderón‐Garcidueñas, L., González-Maciel, A., Reynoso-Robles, R., Hammond, J., Kulesza, R. J., Lachmann, I., Torres‐Jardón, R., Mukherjee, P. S., & Maher, B. A. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110139 · Cited by 98
The immunology of Parkinson’s disease
Zhu, B., Yin, D., Zhao, H., & Zhang, L. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00947-3 · Cited by 108
Review: Prion‐like mechanisms of transactive response DNA binding protein of 43 kDa ( TDP ‐43) in amyotrophic lateral sclerosis ( ALS )
Smethurst, P., Sidle, K. C. L., & Hardy, J. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12206 · Cited by 99
Association between inflammatory bowel diseases and Parkinson's disease: systematic review and meta-analysis
Zhu, Y., Yuan, M., Zhu, Y., Yang, F., Chen, W., Xu, Z.-Z., Xiang, Z.-B., & Xu, R.-S. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.317981 · Cited by 95
Functional amyloids from bacterial biofilms – structural properties and interaction partners
Akbey, Ü., & Andreasen, M. (2022) · Chemical Science · doi:10.1039/d2sc00645f · Cited by 88
Of microbes and minds: A narrative review on the second brain aging
Calvani, R., Picca, A., Lo Monaco, M. R., Landi, F., Bernabei, R., & Marzetti, E. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00053 · Cited by 92
Oral and intravenous transmission of α-synuclein fibrils to mice
Lohmann, S., Bernis, M. E., Babila, J. T., Ziemski, A., Grigoletto, J., & Tamgüney, G. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02037-5 · Cited by 96
Oral Dysbiosis and Inflammation in Parkinson’s Disease
Fleury, V., Zekeridou, A., Lazarević, V., Gaïa, N., Giannopoulou, C., Genton, L., Cancela, J., Girard, M., Goldstein, R., Bally, J. F., et al. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202459 · Cited by 95
Microbiota-gut-brain axis and toll-like receptors in Alzheimer’s disease
Lin, C., Zhao, S., Zhu, Y., Fan, Z., Wang, J., Zhang, B., & Chen, Y. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.09.008 · Cited by 94
Histological Evidence for the Enteric Nervous System and the Choroid Plexus as Alternative Routes of Neuroinvasion by SARS-CoV2
Deffner, F., Scharr, M., Klingenstein, S., Klingenstein, M., Milazzo, A., Scherer, S., Wagner, A., Hirt, B., Mack, A. F., & Neckel, P. H. (2020) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2020.596439 · Cited by 90
Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease
Chen, Q.-Q., Haikal, C., Li, W., & Li, J. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00218 · Cited by 88
Self-citation
Interactions between the microbiota and enteric nervous system during gut-brain disorders
Fried, S. G., Wemelle, E., Cani, P. D., & Knauf, C. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108721 · Cited by 95
Bacterial Chaperones CsgE and CsgC Differentially Modulate Human α-Synuclein Amyloid Formation via Transient Contacts
Chorell, E., Andersson, E. K., Evans, M. L., Jain, N., Götheson, A., Ådén, J., Chapman, M. R., Almqvist, F., & Wittung-Stafshede, P. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140194 · Cited by 88
The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy
Engen, P. A., Dodiya, H. B., Naqib, A. D., Forsyth, C. B., Green, S. J., Voigt, R. M., Kordower, J. H., Mutlu, E., Shannon, K. M., & Keshavarzian, A. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-160991 · Cited by 84
Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome
O’Donovan, S. M., Crowley, E. K., Brown, J. R. ‐., O’Sullivan, O., O’Leary, O. F., Timmons, S., Nolan, Y. M., Clarke, D. J., Hyland, N. P., Joyce, S. A., et al. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13726 · Cited by 86
Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis
Fang, X. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1096271 · Cited by 84
Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson’s Disease
McGee, D. J., Lu, X.-H., & Disbrow, E. A. (2018) · Journal of Parkinson’s Disease · doi:10.3233/jpd-181327 · Cited by 86
Atrophy of the Vagus Nerve in Parkinson's Disease Revealed by High-Resolution Ultrasonography
Walter, U., Tsiberidou, P., Kersten, M., Storch, A., & Löhle, M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00805 · Cited by 86
ɑ‐Synuclein strains and the variable pathologies of synucleinopathies
Peelaerts, W., & Baekelandt, V. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13595 · Cited by 96
Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment
Okuzumi, A., Kurosawa, M., Hatano, T., Takanashi, M., Shuuko, N., Fukuhara, T., Yamanaka, T., Miyazaki, H., Yoshinaga, S., Furukawa, Y., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0587-0 · Cited by 91
Alpha-Synuclein in Peripheral Tissues in Parkinson’s Disease
Ma, L., Liu, G.-L., Wang, D., Zhang, M., Kou, W., & Feng, T. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00383 · Cited by 87
Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy
Rota, L., Pellegrini, C., Benvenuti, L., Antonioli, L., Fornai, M., Blandizzi, C., Cattaneo, A., & Colla, E. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0146-z · Cited by 87
Microbiome changes: an indicator of Parkinson’s disease?
Haikal, C., Chen, Q., & Li, J. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0175-7 · Cited by 83
Self-citation
Accelerated Amyloid Beta Pathogenesis by Bacterial Amyloid FapC
Javed, I., Zhang, Z., Adamčík, J., Andrikopoulos, N., Li, Y., Otzen, D. E., Lin, S., Mezzenga, R., Davis, T. P., Ding, F., et al. (2020) · Advanced Science · doi:10.1002/advs.202001299 · Cited by 83
Alpha Synuclein Connects the Gut-Brain Axis in Parkinson’s Disease Patients – A View on Clinical Aspects, Cellular Pathology and Analytical Methodology
Schaeffer, E., Kluge, A., Böttner, M., Zunke, F., Cossais, F., Berg, D., & Arnold, P. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.573696 · Cited by 87

Authors: Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Björklund, T., Wang, Z.-Y., Roybon, L., Melki, R., & Li, J.-Y.
Affiliations: Lund University (SE)
Centre National de la Recherche Scientifique (FR)
Northeastern University (CN)
ORCID: Holmqvist, Staffan
Bousset, Luc
Aldrin-Kirk, Patrick
Li, Wen
Björklund, Tomas
Wang, Zhan-You
Roybon, Laurent
Melki, Ronald
Venue: Acta Neuropathologica
Publisher: Springer Science and Business Media LLC
Published: 2014-10-09
Volume: 128
Issue: 6
Pages: 805-820
ISSN: 0001-6322 (ISSN-L)
1432-0533
DOI: 10.1007/s00401-014-1343-6
OpenAlex: W1995281235
Cited by: 925
References: 51
Citations by year: 2026: 47 · 2025: 67 · 2024: 73 · 2023: 67 · 2022: 110 · 2021: 132 · 2020: 102 · 2019: 107 · 2018: 75 · 2017: 59 · 2016: 43 · 2015: 38 · 2014: 3
FWCI: 30.94
Type: journal article
Language: en
Open access: green
lup.lub.lu.se
Licence: other-oa
www.springer.com/tdm (tdm)
Locations: Acta Neuropathologica (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Lund University Publications (Lund University) (submittedVersion, other-oa)
Funders: Agence Nationale de la Recherche (ANR-11-BSV8-0021)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords: Parkinson's disease, alpha-synuclein, Lewy bodies, gut-brain axis, vagus nerve, retrograde transport, enteric nervous system, dorsal motor nucleus of the vagus, axonal transport, alpha-synuclein aggregation, rat model
MeSH terms: Animals, Axonal Transport, Brain, Disease Models, Animal, Humans, Parkinson Disease, Recombinant Proteins, Vagus Nerve, Rats, Sprague-Dawley, Disease Progression, Gastrointestinal Tract, Cell Line, Tumor, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks